Key facts
- Bayou Surgical’s last known valuation is $29.0M (Nov 2025).
- It has raised $13.3M across 3 recorded rounds; the latest was Seed Round ($5.0M) in Oct 2025.
- Notable investors include MedTex Ventures.
- Bayou Surgical has filed 2 Form Ds with the SEC since 2020, most recently Aug 2022 ($7.3M sold to 12 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Bayou Surgical
Funding rounds
3 roundsAbout Bayou Surgical
Developer of a surgical device designed to improve the outcomes and efficiency of minimally invasive surgery. The company develops a device that eliminates the problem of impaired visualization during minimally invasive treatments, enabling surgeons to ease the burden of removing and reinserting laparoscopic cameras during operations to improve patient safety and decrease operative time and its associated cost.
- Sector
- Healthcare
- HQ
- Houston, TX, United States
- Founded
- 2016
- Website
- bayousurgical.com/
- Ownership
- Privately Held (backing)
Bayou Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bayou Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bayou Surgical in its N-PORT filings yet. We sweep new filings monthly.